![Xue Jun Cai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Xue Jun Cai
Directeur Technique/Scientifique/R&D chez
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
Profil
Xue Jun Cai is currently an Independent Non-Executive Director at Tyligand Bioscience Ltd., Vice President at Amgen, Inc. since 2014, and Chief Scientific Officer at Shanghai Pharmaceuticals Holding Co., Ltd. since 2024.
Former positions include Medical Director at Pfizer Inc., Director & SVP-Clinical Development at aTyr Pharma, Inc. in 2011, Director-External Affairs & HIV Franchise at Merck Sharp & Dohme Corp., Vice President-Research & Development at AstraZeneca AB, and Principal at Pangu Biopharma, Inc. from 2000 to 2012.
Education includes undergraduate and MBA degrees from The Trustees of Columbia University in The City of New York, and an undergraduate degree from Shanghai Jiao Tong University conferred in 1986.
Postes actifs de Xue Jun Cai
| Sociétés | Poste | Début |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01/01/2014 |
| SHANGHAI PHARMACEUTICALS HOLDING CO., LTD | Directeur Technique/Scientifique/R&D | 01/10/2024 |
Tyligand Bioscience Ltd
 Tyligand Bioscience Ltd BiotechnologyHealth Technology Engages in discovery and development of cancer therapeutics | Directeur/Membre du Conseil | - |
Anciens postes connus de Xue Jun Cai
| Sociétés | Poste | Fin |
|---|---|---|
Pangu Biopharma, Inc. | President | - |
| PFIZER INC. | Directeur Technique/Scientifique/R&D | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Directeur Technique/Scientifique/R&D | - |
Merck Sharp & Dohme Corp.
 Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Corporate Officer/Principal | - |
| ATYR PHARMA, INC. | Directeur/Membre du Conseil | - |
Formation de Xue Jun Cai
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Shanghai Pharmaceuticals Holding Co., Ltd.
 Shanghai Pharmaceuticals Holding Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals products | Health Technology |
Shanghai Jiao Tong University
 Shanghai Jiao Tong University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Pangu Biopharma, Inc. | |
Tyligand Bioscience Ltd
Tyligand Bioscience Ltd BiotechnologyHealth Technology Engages in discovery and development of cancer therapeutics | Health Technology |
